Recent advances in exploring new blood-based biomarkers for the early diagnosis of gastric cancer
Authors:
- 25 November 2024
- journal article
- review article
- Published by Springer Nature in Science China Chemistry
- Vol. 68 (1) , 35-45
Abstract
No abstract availableKeywords
This publication has 104 references indexed in Scilit:
- Combining methylated SEPTIN9 and RNF180 plasma markers for diagnosis and early detection of gastric cancerCancer Communications, 2023
- Polyadenylation ligation‐mediated sequencing (PALM‐Seq) characterizes cell‐free coding and non‐coding RNAs in human biofluidsClinical and Translational Medicine, 2022
- Advances in screening and detection of gastric cancerJournal of Surgical Oncology, 2022
- Circulating Exosomal Gastric Cancer–Associated Long Noncoding RNA1 as a Biomarker for Early Detection and Monitoring Progression of Gastric CancerJAMA Surgery, 2020
- Plasma circular RNA profiling of patients with gastric cancer and their droplet digital RT-PCR detectionJournal of Molecular Medicine, 2017
- Potential of long non‐coding RNAs in cancer patients: From biomarkers to therapeutic targetsInternational Journal of Cancer, 2016
- Circulating CUDR, LSINCT‐5 and PTENP1 long noncoding RNAs in sera distinguish patients with gastric cancer from healthy controlsInternational Journal of Cancer, 2015
- Gastric juice long noncoding RNA used as a tumor marker for screening gastric cancerCancer, 2014
- Clinical significance of circulating tumor cells in peripheral blood from patients with gastric cancerCancer, 2013
- Clinical significance of serum tumor markers for gastric cancer: a systematic review of literature by the Task Force of the Japanese Gastric Cancer AssociationGastric Cancer, 2013